- Home
- LXRX vs NEN Comparison
LXRX vs NEN Comparison
Compare LXRX & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- NEN
- Stock Information
- Founded
- LXRX 1995
- NEN 1977
- Country
- LXRX United States
- NEN United States
- Employees
- LXRX N/A
- NEN N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- LXRX Health Care
- NEN Real Estate
- Exchange
- LXRX Nasdaq
- NEN Nasdaq
- Market Cap
- LXRX 228.8M
- NEN 262.4M
- IPO Year
- LXRX 2000
- NEN N/A
- Fundamental
- Price
- LXRX $1.08
- NEN $73.02
- Analyst Decision
- LXRX Buy
- NEN
- Analyst Count
- LXRX 4
- NEN 0
- Target Price
- LXRX $3.67
- NEN N/A
- AVG Volume (30 Days)
- LXRX 5.0M
- NEN 594.0
- Earning Date
- LXRX 07-31-2025
- NEN 01-01-0001
- Dividend Yield
- LXRX N/A
- NEN 6.49%
- EPS Growth
- LXRX N/A
- NEN 58.97
- EPS
- LXRX N/A
- NEN 4.56
- Revenue
- LXRX $31,213,000.00
- NEN $82,531,485.00
- Revenue This Year
- LXRX N/A
- NEN N/A
- Revenue Next Year
- LXRX N/A
- NEN N/A
- P/E Ratio
- LXRX N/A
- NEN $16.22
- Revenue Growth
- LXRX 1251.21
- NEN 6.12
- 52 Week Low
- LXRX $0.28
- NEN $68.98
- 52 Week High
- LXRX $2.45
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- LXRX 66.94
- NEN 47.71
- Support Level
- LXRX $0.84
- NEN $73.00
- Resistance Level
- LXRX $1.19
- NEN $73.25
- Average True Range (ATR)
- LXRX 0.09
- NEN 0.22
- MACD
- LXRX 0.02
- NEN 0.16
- Stochastic Oscillator
- LXRX 76.60
- NEN 67.11
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.